Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer (Q33418642)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer |
scientific article |
Statements
1 reference
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer (English)
1 reference
Joachim von Pawel
1 reference
Robert Jotte
1 reference
David R Spigel
1 reference
Mary E R O'Brien
1 reference
Mark A Socinski
1 reference
Jörg Mezger
1 reference
Martin Steins
1 reference
Léon Bosquée
1 reference
Jeffrey Bubis
1 reference
Kristiaan Nackaerts
1 reference
José M Trigo
1 reference
Philip Clingan
1 reference
Wolfgang Schütte
1 reference
Martin Reck
1 reference
Manuel Domine
1 reference
Frances A Shepherd
1 reference
Shaoyi Li
1 reference
Markus F Renschler
1 reference
10 November 2014
1 reference
1 reference
Identifiers
1 reference